Cargando…
Dexmedetomidine may upregulate the expression of caveolin-1 in lung tissues of rats with sepsis and improve the short-term outcome
Dexmedetomidine (DXM) is a selective α2-adrenoceptor (α2-AR) and imidazoline receptor (IR) agonist that has been reported to regulate inflammatory responses mediated by diverse signaling pathways through α2-AR. The majority of the reported receptors or downstream molecules have been demonstrated to...
Autores principales: | Zhang, Yun, Ran, Ke, Zhang, Shu-Bin, Jiang, Lili, Wang, Dan, Li, Zhi-Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364843/ https://www.ncbi.nlm.nih.gov/pubmed/28000867 http://dx.doi.org/10.3892/mmr.2016.6050 |
Ejemplares similares
-
Dexmedetomidine attenuates inflammation and organ injury partially by upregulating Nur77 in sepsis
por: Zhang, Qian, et al.
Publicado: (2023) -
Dexmedetomidine May Produce Extra Protective Effects on Sepsis-induced Diaphragm Injury
por: Wu, Jin, et al.
Publicado: (2015) -
Role of Caveolin-1 in Sepsis – A Mini-Review
por: Lannes-Costa, Pamella Silva, et al.
Publicado: (2022) -
Uromodulin Upregulates TRPV5 by Impairing Caveolin-Mediated Endocytosis
por: Wolf, Matthias T.F., et al.
Publicado: (2013) -
Caveolin 1 is Associated with Upregulated Claudin 2 in Necrotizing Enterocolitis
por: Ares, Guillermo, et al.
Publicado: (2019)